Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02449239
Title Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Viventia Bio

bladder urothelial carcinoma


Oportuzumab monatox

Age Groups: senior | adult
Covered Countries USA | CAN

No variant requirements are available.